CD74 and breast carcinoma: In MESO and breast cancer, high CD74 tumor cell expression at different cutoffs of histochemistry score (H-score) (MESO: H-score ≥ 400; breast cancer: H-score ≥ 20) was positively associated with longer survival [34, 36].